Literature DB >> 16341013

Morphine reward in dopamine-deficient mice.

Thomas S Hnasko1, Bethany N Sotak, Richard D Palmiter.   

Abstract

Dopamine has been widely implicated as a mediator of many of the behavioural responses to drugs of abuse. To test the hypothesis that dopamine is an essential mediator of various opiate-induced responses, we administered morphine to mice unable to synthesize dopamine. We found that dopamine-deficient mice are unable to mount a normal locomotor response to morphine, but a small dopamine-independent increase in locomotion remains. Dopamine-deficient mice have a rightward shift in the dose-response curve to morphine on the tail-flick test (a pain sensitivity assay), suggesting either a decreased sensitivity to the analgesic effects of morphine and/or basal hyperalgesia. In contrast, dopamine-deficient mice display a robust conditioned place preference for morphine when given either caffeine or l-dihydroxyphenylalanine (a dopamine precursor that restores dopamine throughout the brain) during the testing phases. Together, these data demonstrate that dopamine is a crucial component of morphine-induced locomotion, dopamine may contribute to morphine analgesia, but that dopamine is not required for morphine-induced reward as measured by conditioned place preference.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341013     DOI: 10.1038/nature04172

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  Social bonding decreases the rewarding properties of amphetamine through a dopamine D1 receptor-mediated mechanism.

Authors:  Yan Liu; Kimberly A Young; J Thomas Curtis; Brandon J Aragona; Zuoxin Wang
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.

Authors:  Cindy Achat-Mendes; Laurie J Lynch; Katherine A Sullivan; Eric J Vallender; Gregory M Miller
Journal:  Pharmacol Biochem Behav       Date:  2011-11-04       Impact factor: 3.533

Review 3.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

Review 4.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

5.  Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat.

Authors:  Jocelyn M Breton; Annabelle R Charbit; Benjamin J Snyder; Peter T K Fong; Elayne V Dias; Patricia Himmels; Hagar Lock; Elyssa B Margolis
Journal:  J Comp Neurol       Date:  2018-12-11       Impact factor: 3.215

Review 6.  Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Authors:  Paul E M Phillips; Mark E Walton; Thomas C Jhou
Journal:  Psychopharmacology (Berl)       Date:  2006-11-22       Impact factor: 4.530

7.  Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.

Authors:  Seung-Nam Kim; Ah-Reum Doo; Ji-Yeun Park; Hyunwoo J Choo; Insop Shim; Jongbae J Park; Younbyoung Chae; Bena Lee; Hyejung Lee; Hi-Joon Park
Journal:  Brain Res       Date:  2013-12-07       Impact factor: 3.252

Review 8.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

Review 9.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

10.  Overinhibition of corticostriatal activity following prenatal cocaine exposure.

Authors:  Wengang Wang; Ioana Nitulescu; Justin S Lewis; Julia C Lemos; Ian J Bamford; Natasza M Posielski; Granville P Storey; Paul E M Phillips; Nigel S Bamford
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.